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1. Introduction 
Orthotopic liver transplantation (OLT) became a treatment modality in Denver (Starzl et al., 
1963) and Cambridge, England in 1968 (Calne, 2008) although exposing critically ill patients 
to extensive surgery was a challenge and in the 1970s, the one year survival rate remained in 
the vicinity of only 25% (Starzl et al., 1981). One problem was to manage the often 
impressive blood loss and rapid infusion devices were developed to provide large amounts 
of blood products at body temperature (Stammers et al., 2005). During OLT the blood loss 
has, fortunately, declined and in the 1980s, the average number of blood units administered 
was reduced to 20 and in some centres, ~ 80% of patients are now without a need for 
administration of blood (Massicotte et al., 2004). Yet, there remains differences among 
centres and for a number of patients, OLT is associated with a significant blood loss 
(Massicotte et al., 2004). Furthermore, haemodynamic challenges are inevitable during the 
operation. Corresponding to the metabolic activity of the liver, the hepatectomy is likely to 
reduce cardiac output (CO) and in cases for which caval and portal clamping are used, 
blood accumulates in the splanchnic region and in the lower part of the body which together 
leads to a decline in CO by 40%-50% (Ozier & Klinck, 2008). Conversely, CO often doubles 
during reperfusion of the grafted liver as peripheral vasodilatation is provoked by the 
release of blood from the splanchnic region mixed with the chilled outflow from the liver, 
potentially with a high potassium concentration (Ozier & Klinck, 2008). Also it may be that 
the heart is unable to respond with an adequate increase in CO to reperfusion of the grafted 
liver, or that there is a reduction in CO despite an, apparently, adequate central blood 
volume (CBV), accepting that reperfusion of the liver and re-establishing splanchnic blood 
flow may release some cardio-inhibiting factor (Jordan et al., 1999). Given redistribution of 
the blood volume during OLT, monitoring of the circulation is, ideally, directed to secure 
CBV rather than the total blood volume.  
As for other types of surgery, there is no universally accepted strategy for haemodynamic 
monitoring during OLT, save a mandatory arterial line and recording of heart rate (HR) by 
ECG (Ozier & Klinck, 2008). Yet, mean arterial pressure (MAP) and HR are inadequate for 
monitoring CBV (Bundgaard-Nielsen et al., 2007a). For example, there may be no significant 
deviations in these variables until a hypovolaemic shock is provoked (Murrell et al., 2009). 
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Furthermore during surgery, HR and especially MAP are affected by the anaesthetic agents 
and by the surgical stress (Ejlersen et al., 1995a). Despite these limitations in the use of HR 
and MAP to detect deviations in CBV, the capability to balance CBV is of importance for 
tissue perfusion and oxygenation and notably for oxygenation of the brain (ScO2) (Nissen et 
al., 2009a), indicating that advanced cardiovascular monitoring is required to secure the 
well-being of the patient (Yao et al., 2004;Bundgaard-Nielsen et al., 2007a;Murkin et al., 2007) 
In order to maintain CBV during surgery, it is important that normovolaemia is defined. For 
supine humans the heart operates on the upper flat part of the Frank-Starling curve (Harms 
et al., 2003) and to establish and to maintain a maximal resting stroke volume for the heart 
(or CO) secures that the patient remains normovolaemic during the operation and that fluid 
administration strategy reduces postoperative complications to an extent that affects the 
hospital stay (Bundgaard-Nielsen et al., 2007a). Such goal directed fluid therapy was 
introduced by Shoemaker et al. (Shoemaker, 1972;Shoemaker et al., 1988) in regard to CO but 
without taking the individual and partly genetically determined differences in CO (Snyder 
et al., 2006) into account. Accordingly, this chapter focuses on how normovolaemia can be 
established and maintained during OLT despite the difficulties confronting the definition of 
normovolaemia by the spontaneous changes in stroke volume, CO and (mixed) venous 
oxygen saturation (SvO2) during the different phases of the operation. A second goal of this 
chapter is to introduce devices that can be applied for intraoperative monitoring of CBV and 
ScO2. Focus is on the importance of maintaining a normal CBV to secure cerebral blood flow 
(CBF) and ScO2 since these variables are taken to express the integrity of the cardiovascular 
system and their defence, at least potentially, prevents postoperative complications and 
cognitive dysfunction (Murkin et al., 2007). In addition, the volume administration strategy 
applied during the operation is addressed. 
2. Normovolaemia  
By definition it seems difficult to defend that any patient should be provided with a fluid 
overload or be maintained hypovolaemic and yet, even hypovolaemic shock is sometimes 
treated with sympatomimetic drugs (De Backer D. et al., 2010). For balancing volume 
administration it is of interest that normovolaemia can not only be defined but also 
defended during surgery. For healthy supine humans stroke volume, CO, and SvO2 do not 
respond to expansion of CBV and, therefore for supine humans, a volume administration 
strategy that secures that the heart operates on the upper ceiling of the Frank-Starling curve 
maintains the patient normovolaemic (Harms et al., 2003;Jans et al., 2008;Bundgaard-Nielsen 
et al., 2009c) (Fig. 1).  
For individualized goal-directed fluid therapy, volume is administered until a flow related 
parameter such as stroke volume, CO or SvO2, reaches a maximal value (Jenstrup et al., 
1995), i.e. volume is administrated until cardiac function does not depend on preload to the 
heart. This volume administration strategy is of interest not only because it remains elusive 
what volume rate a fixed volume administration strategy should aim at (Bundgaard-Nielsen 
et al., 2009b), but also because an individualized fluid administration strategy, in contrast to 
a fixed volume strategy, consistently improves outcome for surgical patients (Bundgaard-
Nielsen et al., 2007a; Lopes et al., 2007; Donati et al., 2007; Abbas & Hill, 2008; Mayer et al., 
2010).  
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Fig. 1. Relationship between systemic haemodynamic variables, mixed venous oxygen 
saturation and tilt angle. BP, systolic, mean and diastolic blood pressure; HR, heart rate;  
CO, cardiac output; SvO2 mixed venous oxygen saturation. Variables are mean ± S.E.M.  
# P < 0.05 vs. 0 deg. Dashed line represents the supine position; 70 a, 70 deg head-up tilt for 
10 min; 70 b, last minute of 70 deg head-up tilt for nine subjects (From Harms et al., 2003 
with permission) 
Based on administration of a crystalloid or a colloid, an inherent difficulty for 
individualized goal directed fluid therapy is, however, that a reduction in haematocrit is 
associated with an increase in CO, i.e. normovolaemic haemodilution increases CO (Krantz 
et al., 2005). In other words, it is not CO but SvO2 that is the regulated variable since the red 
cells create their own flow regulation through the release of ATP and NO when oxygen is 
released from oxyhaemoglobin (Gonzalez-Alonso et al., 2006). To direct fluid administration 
on the basis of establishing maximal values for stroke volume or CO requires that there is 
added a rule to limit the fluid administered. A common algorithm implies that a 10%, or 
larger increase in stroke volume justifies further administration of 200–250 ml of colloid, 
thereby minimizing the risk of creating a fluid overload (Bundgaard-Nielsen et al., 2007a). In 
contrast, during isovolaemic haemodilution, SvO2 remains stable until the haemoglobin level 
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is reduced by approximately 50% (Krantz et al., 2005) and volume administration based on 
the recording of ScO2 is therefore widely independent of the type of fluid used. 
When CBV is normalized by fluid to establish a maximal SvO2, the administration of 100 
ml fluid results a ~1% increase in SvO2 for the adult patient (~ 70 kg) (Ejlersen et al., 1995a) 
and that relationship applies also to children when the volume is adjusted according to 
body weight. For supine humans, SvO2 is on an average 75% (Harms et al., 2003) but for 
patients undergoing OLT, SvO2 is typically ~ 85% (Ejlersen et al., 1995b) reflecting that for 
these patients CO is larger (7-9.5 l/min) (Table 1) than for a reference population (6.5 
l/min). 
 Dissection 
phase 
Anhepatic 
phase 
Reperfusion End of 
operation 
HR (bpm) 95 90 87 97 
CI (l m-1 min-1) 4.4 3.3 5.0 4.5 
SvO2 (%) 85 81 86 82 
TA (Ohm) 29 28 29 26 
MAP (mmHg) 88 89 85 87 
CVP (mmHg) 10 10 14 11 
PAMP (mmHg) 18 17 26 21 
SVRI (mmHg m2 min l-1) 142 195 105 120 
PVRI (mmHg m2 min l-1) 11 14 9 12 
Temperature 36 35 35 35 
HR, hear rate; CI, cardiac index; SvO2, mixed venous saturation; TA, thoracic electric admittance; MAP, 
mean arterial blood pressure; CVP, central venous pressure; PAMP, pulmonal arterial mean pressure; 
SVRI, systemic vascular resistance index; PVRI, pulmonal vascular resistance index (Modified from 
Skak et al., 1997). 
Table 1. Cardiovacular variables during OLT 
Reperfusion of the grafted liver is associated with peripheral vasodilatation and although 
CO is likely to increase (Table 1), situations associated with peripheral vasodilatation, as 
during heating (Wilson et al., 2009), are likely to reduce CBV. The importance of establishing 
normovolaemia from the induction of anaesthesia is illustrated by an increase in ScO2 as 
determined by near infrared spectroscopy (NIRS) and similarly determined muscle 
oxygenation (SmO2) since both these indices of tissue oxygenation increase in parallel with 
CO as the heart becomes filled with blood and decrease with the filling of the heart during a 
bleeding episode (Fig. 2). 
Conversely, to maintain the commonly accepted 70% value for SvO2 (Rivers, 2006) is likely to 
represent a 1.5 l volume deficit for the patient undergoing OLT, considering the 1% 
reduction in SvO2 to 100 ml blood volume relationship during hypovolaemia (Ejlersen et al., 
1995a). A 1.5 l volume deficit is so large that it compromises MAP and ScO2 (Secher et al., 
1992) since a ~30 % reduction of the blood volume and, hence CBV elicits a Bezold-Jarisch-
like reflex including a critical reduction in CBF (van Lieshout et al., 2003;Secher & van  
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Fig. 2. Venous (SvO2) and muscle oxygen saturation (SmO2) plotted together with filling of 
the left ventricle (LVAd), and volume balance in a patient exposed to an episode of 
intraoperative bleeding and following volume expansion (C. Tollund unpublished) 
Lieshout, 2009;Madsen & Secher, 1999). The Bezold-Jarisch-like reflex also provokes a 
marked (30-fold) increase in plasma vasopressin (Sander-Jensen et al., 1986)  with long-
lasting effect on urine production and could explain a potential difficulty in maintaining a 
reasonable urine production after surgery. Typically, the patients are in need of 0.5 l of 
volume before OLT (Ejlersen et al., 1995b), a value that corresponds to that found also for 
other groups of patients before surgery (Jenstrup et al., 1995;Bundgaard-Nielsen et al., 
2007b;Bundgaard-Nielsen et al., 2009a). If it is felt desirable to maintain urine production, 
it is important that such an initial volume deficit is corrected and, eventually, a larger 
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fluid load may be required than that which establishes that the patient has been provided 
with a normal blood volume. For additional volume threatment of patients, the 
administration of lactated Ringer solution is preferable to the administration of saline 
(Waters et al., 2001). 
3. Cardiac output 
With a definition of normovolaemia based on the ability of the heart to establish an 
adequate flow, CO is of interest. As mentioned, patients undergoing OLT present a large CO 
while MAP may be low (el-Masry et al., 2009; Ejlersen et al., 1997). Yet MAP often normalises 
when the blood volume, and hence CBV, is expanded to an extent that it does not limit CO, 
i.e. the patients are provided with the CBV that healthy subjects are provided with when 
supine (Harms et al., 2003). However, significant ascites may affect venous return to the 
heart by pressure on the inferior caval vein that can be relieved by tilting the patient to the 
left - as known from women before birth - but that pressure is eliminated as the abdominal 
cavity is opened at start of surgery. As indicated, however, OLT is associated with significant 
changes in the cardiovascular system from the dissection phase to the anhepatic phase and 
following reperfusion of the donor liver and CO normalises only slowly by the end of the 
operation (Table 1).  
To attenuate a reduction in venous return to the heart from the clamped inferior caval vein 
during the hepatectomy and insertion of the donated liver and thereby stabilize CO, an 
extra-corporeal veno-venous bypass shunt (VVBP) can secure portal and femoral venous 
drainage to one or two veins on the arm or to a central venous access (Ozier & Klinck, 
2008). Veins on the arm are preferred to central veins to avoid that blood accumulates in 
the mediastinum in the case the catheter(s) has perforated the vein(s). Before a central vein 
receives blood from the shunt, it needs to be secured that blood can be aspirated from the 
catheter. The VVBP has a flow of 1.5-3 l/min, but for children and patients with a portal 
hypertension, venous return to the heart may be maintained by spinal and abdominal 
veins and veins along the oesophagus and there may, accordingly, be no need for a VVBP 
in these patients accepting substantial accumulation of blood in the splanchnic region. Yet 
surgical bleeding may be reduced if blood does not accumulate in distended abdominal 
veins.  
At any rate, blood accumulates in the splanchnic region while the portal vein is clamped for 
establishing the VVBP and when it is seponated the accumulated amount of blood helps to 
fill the donor liver. Alternatively, the “piggyback” technique for which the inferior caval 
vein is side-clamped can reduce the restrain on venous return to the heart during the 
hepatectomy and surgery on the vessels to the donor liver. Notably, stability of the 
circulation is secured if reperfusion of the liver is graded by declamping the caval vein 
above the liver followed by declamping the vein below the liver and thereafter establishing 
its arterial flow. 
3.1 Monitoring of cardiac output 
For monitoring of CO several methods are applicable and not all will be addressed here. 
Ideally the chosen method should be reliable, continuous, and easy to set-up and to use and  
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at the same time possess the capability for a fast response time. Of these priorities, the 
accuracy of the absolute value is of least relevance due to the marked inter-individual 
variations in CO among the patients, e.g. 2.5 to 17 l min-1 (Nissen et al., 2009b) and the often 
2-fold change in CO during the operation, but the method should be able, at all times, to 
report the changes in CO faithfully and most importantly so during reperfusion of the 
grafted liver. 
A pulmonary artery catheter (PAC) determines CO by thermodilution based on the 
Henriques-Stewart-Hamilton equation (Pinsky, 2007) and is for clinical use regarded as the 
golden standard, but it then requires an average of three or probably four determinations 
(Nilsson et al., 2004) based on bolus injection of (10 ml) cooled saline. Furthermore, it 
remains a problem that the baseline temperature is often too unstable to make a 
thermodilution determination of CO possible within the first minutes after reperfusion of 
the grafted liver. That problem is exaggerated with the version of PAC that uses heating 
filaments for “continuous” CO determination because the appreciated change in temperature 
is small and it may take 15 –20 min, or more, after reperfusion of the grafted liver before 
such a CO can be determined (De Wolf, 2006; Bao & Wu, 2008). 
The advantage of transoesophageal echocardiography (TEE) is that it provides a real-time 
image of the heart and thereby on-line information not only about filling of the heart but 
also about the structure and contractility of the myocardium (Della et al., 2009) of relevance 
especially during reperfusion of the grafted liver in case CO does not increase. Thus, TEE 
allows for distinction between a need for administration of volume versus sympatomimetic 
drugs. Unfortunately, however, mainly cardiac anaesthesiologists are familiar with the use 
of TEE and it remains a concern that TEE requires high costs and a need for training (Della et 
al., 2009). It should also be mentioned that although individualized goal directed fluid 
administration aims at filling the heart with blood (Figs. 1 and 2), a detailed TEE evaluation 
of whether that is the case requires off-line evaluation. 
Studies comparing CO determined by transoesophageal echo-Doppler (TED) against PAC 
show conflicting results (Shimamoto et al., 1992; Boucaud et al., 2008; Laupland & Bands, 
2002; Colbert et al., 1998) although there seems to be agreement to that changes in CO are 
reflected by TED. A disadvantage with TED is, however, frequent dislocation of the 
ultrasound probe (Lefrant et al., 1998) of relevance for the in general long-lasting OLT and 
TED is counter-indicated in patients with oesophageal disorders of relevance for many of 
the OLT patients and once a Doppler probe is in place it hinders TEE (de Waal et al., 2009). 
For continuous recording of CO, several methods appreciate the arterial waveform. The 
PiCCO and LiDCO generate a continuous CO by analysis of the arterial pulse pressure (PP). 
For both methods, an independent technique is used to calibrate the continuous CO analysis 
since the arterial pulse-pressure analysis does not account for variables such as changing 
compliance of the vascular bed. Recalibration of CO is recommended after changes in 
patient position, therapy, or condition (de Waal et al., 2009) of relevance for OLT encompassing 
marked changes in the vasculature through the different phases of the operation. 
In the case of PiCCO, transpulmonary thermodilution is used for calibration. As with the 
PAC, PiCCO appreciates transpulmonary thermodilution according to the Henriques-
Stewart-Hamilton principle but considers that a determination of a change in temperature 
from a central venous line to an arterial line (e.g. femoral or axillary) is less invasive than a 
determination based on a PAC catheter. The CO derived from this cold-saline 
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thermodilution is used to calibrate the arterial pulse-pressure contour that then provides the 
continuous CO. The PiCCO algorithm appreciates the blood pressure waveform 
morphology (i.e. mathematical analysis of the pulse-pressure waveform) and calculates a 
continuous CO as described by Wesseling et al (Wesseling et al., 1993). Transpulmonary 
thermodilution includes both the right and left side of the heart as well as the pulmonary 
circulation and that allows for further analysis of the thermodilution curve with measures of 
the cardiac filling volume, the intrathoracic blood volume, and the extravascular lung water, 
the latter addressing wheather pulmonary oedema is developed (Oren-Grinberg, 2010; 
Costa et al., 2007). Accepting that transpulmonary thermodilution may be a less invasive 
procedure for determination of CO than one based on PAC, it is also less accurate and still 
requires central venous and arterial lines. 
In the case of LiDCO, the independent calibration technique is lithium dilution, again 
according to the Henriques-Stewart-Hamilton principle. LiDCO uses lithium dilution from a 
peripheral vein to an arterial line and, thereby, does not express information on cardiac 
filling volumes or the extravascular lung water. It is also a concern that calibration cannot be 
performed frequently and calibration may be unreliable in patients with grave hyponatreamia 
(Morgan et al., 2008) that may manifest in some OLT patients. The PulseCO algorithm used 
by LiDCO is based on pulse power derivation rather than on waveform morphology. 
Continuous tracking of changes in stroke volume by arterial pulse wave analysis in 
Modelflow provides flow from pressure and has the potential to appreciate the importance 
of systemic blood flow (Wesseling et al., 1993;Harms et al., 1999). With Modelflow®, beat-to-
beat CO is estimated from the arterial pressure wave (Wesseling et al., 1993). Pressure from 
an arterial line is, after calibrating and zeroing to the mid-axillary level used as input to the 
model to calculate CO. The method uses a non-linear three-element model of the aortic 
input impedance and simulates the aortic flow waveform from the pressure signal. Two of 
the three model elements (aortic characteristic impedance and arterial compliance) depend 
on the elastic properties of the aorta and are computed using a built-in database of 
arctangent aortic pressure-area relationships given age and gender of the patient. 
Integrating the aortic flow waveform per beat provides left ventricular stroke volume and 
CO is the product of stroke volume and HR while the third model element, peripheral 
vascular resistance is calculated for each heartbeat as the quotient of arterial pressure to CO 
(Fig. 3A). The software used is an online real-time version of Beatscope® (FMS, Amsterdam, 
The Netherlands).  
The Modelflow method is fully automatic, self-recording, has a fast response time, a high 
precision, and has been successfully validated against a thermodilution estimate of CO 
during cardiac surgery (Jansen et al., 2001), intensive care medicine (Jansen et al., 
2001;Jellema et al., 1999), and notably during OLT (Nissen et al., 2009b)  and, surprisingly, 
without a need for taking potential differences in vascular tone during the operation into 
account (Fig. 3 B). That is the case although Modelflow appears to underestimate deviations 
in CO during manipulation of body temperature with a significant increase in vascular 
conductance during heating (Shibasaki et al., 2011). 
4. Thoracic electric admittance  
With the large spontaneous changes in CO during OLT, it may be an advantage to monitor 
CBV separately and, as indicated, evaluate the pulmonary water content. According to  
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(a) 
 
(b) 
Fig. 3. a) Diagram of the three-element non-linear, self-adapting model (right) and input 
pressure and simulated flow pulse (left) used for Modelflow. Arterial pressure p is applied 
to the model input. Zo, characteristic impedance of the proximal aorta; Cw, arterial Windkessel 
compliance; Rp total systemic peripheral resistance. The non-linear properties of Z0 and Cw 
are indicated by a stylised ”S” symbol. Rp has an arrow indicating that it adapts to changes 
in systemic resistance. The result of the model simulation is a flow curve q. Integrated per 
beat (area under the curve) yields stroke volume. (From Wesselring et al. 1993 with 
permission). b) Cardiac output followed by Modelflow (MCO) and thermodilution (TDCO) 
during liver transplantation surgery. (From Nissen et al., 2009 b with permission) 
Ohm’s law changes in CBV can be assessed by thoracic electrical admittance (TA) and the  
obtained value is expressed in milli-Siemens (mS). Using a low  (e.g. 1.5 kHz) and a high 
frequency current (e.g. 100 kHz), TA distinguishes between the extracellular (TA1.5) and 
total water (TA100) content. Accordingly, changes in the difference between the high and the 
low frequency current reflects those in the intracellular water content (TAICW) (Cai et al., 
2000), i.e. red cell volume within the thoracic region (Fig. 4) and TAICW can, thereby, indicate 
a need for transfusion of blood while TA1.5 monitors the (pulmonary) water content. 
With the use of goal-directed approach to the administration of fluid and blood information 
about CBV becomes important in the anhepatic phase of OLT when approximately one third 
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of the circulation is eliminated causing a similar decrease in CO (Table 1), not necessarily 
due to hypovolaemia. Similarly when the donor liver is reperfused, an increase in CO 
requires that CBV is maintained despite the blood needed to fill the liver, while care is 
directed also to avoid distension of the liver by administrating a too large volume load. 
With TA, evaluation of CBV is continuous with the use of, e.g. two ECG electrodes on the 
right side of the neck and two other electrodes placed high in the midaxillay line on the left 
side of the thorax (Ejlersen et al., 1997;Matzen et al., 1991) in order to include the heart and 
central vessels in the evaluation and at the same time exclude the abdominal fluid content. 
With a four electrode arrangement, skin resistance is eliminated from the evaluation making 
changes in TA an almost perfect report of those in the thoracic fluid / blood volume (Krantz 
et al., 2000). Similarly, it is possible to monitor accumulation of blood in the legs during 
cross-clamping of inferior caval vein by changes in TA over one leg or the glutal region 
(Ejlersen et al., 1997). 
 
Fig. 4. At low and high frequencies, thoracic electric admittance (TA) distinguishes between 
the extracellular (ECW) and total body water (TBW). The difference reflects the intracellular 
water content (ICW) and changes respond to haemorrhage versus administration of blood 
When volume is administered according to individualised goal directed fluid therapy, an 
increase in TA reflects that CBV is increased, as does pulmonary artery mean and wedge 
pressures and that is the case although there may be no changes in HR, central venous 
pressure (CVP), or MAP as CO increases during OLT (Ejlersen et al., 1995b). 
5. Venous saturation 
For continuous reading of SvO2, a PAC catheter is ideal but a central SvO2 may be similarly 
obtained from a central venous line using a catheter with the same type of fiberoptic 
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oxymeter. Central SvO2 values are about 5% larger than those obtained from the PAC 
catheter (Krantz et al., 2005; Rivers, 2006) but with parallel changes in response to 
deviations in blood volume (el-Masry et al., 2009; Krantz et al., 2005). Alternatively, SvO2 
may be obtained by blood sampling during the different phases of the operation or, 
eventually, at times when there is a need to check volume administration during a major 
blood loss. 
Thus, in order to evaluate whether a hypotensive incident is due to a reduced CO or to a 
reduced afterload, monitoring of SvO2 is well suited (Fig. 2). Considering that the patient’s 
(basal) metabolic rate (Vo2) does not change during the operation (despite the hepatectomy), 
there is a direct relationship between SvO2 and CO as described by Fick’s equation: (Vo2 = 
(Ca – Cv) Q), where Ca and Cv represent the arterial and venous oxygen content. Therefore, a 
continuous recording of SvO2 may be applied in situations where devices for continuous 
recording of stroke volume or CO are not available of relevance, as mentioned, especially for 
the first minutes after reperfusion of the donor liver. Typically, a low arterial pressure 
reflects a blood loss in the dissection phase of the operation, while reperfusion of the liver is 
likely to be associated with a low blood pressure due to loss of peripheral resistance as 
detected by an increase in muscle blood flow as recorded easily by an increase in muscle 
oxygenation (SmO2). Surprisingly, also CBF increases during reperfusion of the grafted liver 
despite MAP may decrease to a level that is lower than normally considered to represent the 
lower level of cerebral autoregulation (60 mmHg) and an increase in the arterial carbon 
dioxide tension (PaCO2) seems only partly to explain an elevated CBF during reperfusion of 
the liver (Pott et al., 1995; Larsen et al., 1999). However, during reperfusion of the liver, 
function of the heart may be affected by a lowering of HR in response to an abrupt increase 
in plasma potassium as detected by blood sampling or indicated by the ECG and before the 
liver is reperfused, a small dose of adrenaline (4-6 μg kg-1 h-1) prevents this slowing of the 
heart since adrenaline promotes clearance of potassium from the circulation (Struthers et al., 
1983) besides its chronotropic effect. 
Generally, a reduction in SvO2 should be considered as an indication for a low CO due to 
hypovolaemia and treated accordingly by applying the principles of individualised goal 
directed fluid therapy. That is the case although with the often marked increase in CO 
during early reperfusion of the grafted liver, SvO2 may reach extreme values (>95%) and, as 
mentioned, TA can indicate whether CBV is maintained or whether further volume 
treatment would be likely to increase CO even more and thereby stabilize MAP. Thus SvO2 
values derived from either a PAC or a central venous catheter have potential as variables for 
goal directed fluid therapy (Fig. 2) although outcome and comparative studies are available 
only in regard to monitoring stroke volume or CO (Bundgaard-Nielsen et al., 2007a). 
6. Vascular pressures 
Monitoring arterial pressure is often by way of a catheter in the radial artery, but in case of 
central hypovolaemia, the radial artery constricts to dilate again as the hypovolaemic shock 
develops (Iversen et al., 1995) making the pressure in the radial artery a potential 
underestimate of the systemic pressure (De Wolf, 2006; Krenn & De Wolf, 2008). In contrast, 
the use of a femoral artery catheter is reliable for recording of MAP (Arnal et al., 2005) but 
never the less, a radial artery catheter can be used for blood sampling and as back-up for the 
determination of MAP. For example in case the hepatic artery needs to be grafted to the 
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aorta, partial or complete clamping of the abdominal aorta may eliminate pressure 
recording in the femoral artery.  
The CVP is often taken to express filling of the right ventricle but CVP is not well correlated 
with preload to the heart as expressed by its diastolic filling (De Wolf, 2006). A correlation 
between CO and CVP is established during acute changes in the CBV as induced by head-
up-tilt (Ogoh et al., 2003) or lower body negative pressure (Murray et al., 1999), while for 
most patients CO is not related to CVP although there is a relation between CO and diastolic 
filling of the heart as indicated by echocardiography (Thys et al., 1987).  
In order to limit the blood loss during surgery, a strategy of keeping CVP low has been 
suggested and studies on liver resection patients show a reduction in the blood loss, in 
morbidity, as in the hospital stay when the intraoperative CVP is kept < 5 mmHg (Jones et 
al., 1998;Chen et al., 2000). Implementing the same strategy to OLT, one study found that a 
low CVP increased morbidity as expressed as postoperative renal failure and mortality 
(Schroeder et al., 2004), while an other study came to the opposite conclusion (Massicotte et 
al., 2006). We hold it that volume therapy during OLT is better detected by flow related 
parameters than by vascular pressure(s) (Bundgaard-Nielsen et al., 2007a;Jenstrup et al., 
1995;Ejlersen et al., 1995b). 
A PAC allows for monitoring pulmonary artery (mean) pressure (PAMP) as well as wedge 
pressure (PAWP). These values are relevant to patients undergoing OLT since some patients 
develop both portal and pulmonary hypertension (Krenn & De Wolf, 2008). It remains, 
however, elusive whether monitoring of PAWP provides advantages over the continuous 
recording of PAMP. At least it should be considered that a determination of PAWP carries 
the risk of rupturing a branch of the pulmonal artery and that is likely to be fatal.  
 
Fig. 5. Pulmonary artery mean pressure (PAMP) (±SD and 5th and 95th percentile) and 
cardiac output (CO) (±SD) for 33 candidates for OLT at rest and during exercise (P. Nissen, 
unpublished) 
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A PAMP limit of 30 mmHg may be considered to indicate pulmonary hypertension, but it 
should be taken into account that there is a direct relationship between PAMP and CO as 
illustrated during physical exercise (Tolle et al., 2008) and that is also the case for patients 
under evaluation for OLT (Fig. 5). 
If a candidate OLT patient presents a high PAMP, it should accordingly be considered 
whether the high pulmonary pressure is because of a large CO and thereby unrelated to 
pulmonary disease. As for other patient categories, it seems more important that the heart is 
able to generate a reasonable CO than at what pressures it operates. For example, a 
successful OLT is reported for a patient with a PAMP of 44 mmHg and a CO of 5.7 l/min 
and with an ability to increase CO to 10 l/min (at a PAMP of 51 mmHg during reperfusion 
of the liver) (Liu et al., 1996). Similarly, there is even for patients without pulmonary 
hypertension an often impressive increase in PAMP concomitant with the increase in CO 
during reperfusion of the grafted liver (Table 1). Furthermore hypoxia leads to pulmonary 
hypertension of relevance for OLT patients with associated significant pulmonary shunt and 
at least in case of hypoxia, pulmonary hypertension seems to be related to the patient’s iron 
status (Smith et al., 2008). Accordingly, the iron status of the OLT candidate with pulmonary 
hypertension and hypoxia should be checked. 
7. Heart rate 
It is probably without exception that HR is monitored during OLT and deviations in HR in 
response to variation in CBV are therefore of interest. In textbook descriptions of 
hypovolaemic shock it is stated often that tachycardia is the arterial baroreceptor response 
to a low blood pressure (Secher & Bie, 1985). Yet the common, both experimental and 
clinical finding is that the HR response to central hypovolaemia encompasses three stages 
(Secher et al., 1992) (Fig. 6).  
With a small reduction in CBV, there is a moderate increase in HR, most often to less than 
100 bpm and as indicated, the increase in HR may be so small that it does not become 
statistically significant (Murrell et al., 2009). However, with a 30% reduction of CBV, both 
HR and MAP decrease as known from a vasovagal syncope and cerebral perfusion and 
oxygenation become affected (Madsen & Secher, 1999;van Lieshout et al., 2003). Such an 
incident is fatal if CBV is not restored immediately (Madsen et al., 1998), but with partial 
restoration of CBV, intense sympathetic activation in response to (central) hypovolaemia 
elicits a marked increase in HR (>120 bpm) may be in response to cerebral hypoperfusion. 
Thus, adequate restoration of CBV in stage II of shock secures the well-being of the patient, 
while manifest tachycardia (stage III) appears to indicate a transition to an irreversible stage 
of shock since the patient then is likely to need eventually prolonged intensive care and is 
then exposed to the associated grave prognosis (De Backer D. et al., 2010). It should also be 
noted that the administration of atropine to treat bradycardia during haemorrhage is likely 
to enhance the haemorrhage and, thereby, could be fatal (Bertolini, 1995). At any rate, the 
administration of atropine hinders the use of HR to monitor an eventual volume deficit. In 
case of a low HR, volume should be administrated with an expected moderate increase in 
HR before the “resting” HR is established (Fig. 6). Conversely, it should be checked whether 
any increase in HR is due to an otherwise undetected (small) volume deficit by 
supplementing (100-200 ml) of volume and thereby keep HR low and the volume 
administration can then stop when HR does not decrease further. 
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Fig. 6. Heart rate (HR) and blood pressure (systolic v and diastolic ^) responses of a patient 
treated for a ruptured abdominal aneurism. At admission the patient had thacycardia and 
low blood pressure (stage III of hypovolaemic shock). During volume loading a decrease in 
HR (stage II) is seen followed by an increase (stage I, preshock) as blood pressure began to 
increase before stable values were reached; beginning and end of the operation indicated by 
circles. (From Jacobsen & Secher, 1992 with permission) 
8. Cerebral autoregulation 
Central to this chapter is the ability to secure CBF and ScO2 during the OLT and thereby, 
presumably, maintain the patient’s well being after the operation (Murkin et al., 2007).  
Interest in recording CBF or ScO2 for the OLT patient is relevant not only because these 
variables may be affected by hypotensive events during the operation in case a low blood 
pressure reflects a reduced CO, but also because some acute liver disease patients 
demonstrate impaired cerebral autoregulation (Larsen et al., 1999; Nissen P. et al., 2009; 
Ejlersen et al., 1994) (Fig. 7). 
Cerebral perfusion may be followed by transcranial Doppler (TCD) derived middle cerebral 
artery mean blood velocity (MCA Vmean) (Pott et al., 1995) and evaluation of cerebral tissue 
flow by clearance of 133Xe has been carried out during OLT(Larsen et al., 1999). However, it 
remains that NIRS is, by far the most feasible method for routine monitoring of cerebral 
perfusion during surgery (Nissen et al., 2009a;Steiner et al., 2009). NIRS reflects changes in 
brain capillary saturation and mitochondrial oxygen tension in response to manipulation of 
the inspired oxygen and CO2 tensions (Rasmussen et al., 2007) although a potential influence 
of skin blood flow needs to be considered (Sato et al., 2011). 
While a determination of CBF requires extensive apparatus and calculations, the recording 
of ScO2 is as readily available as the recording of arterial oxygen saturation by pulsoximetry  
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Fig. 7. Changes in frontal lobe cerebral oxygen saturation (ΔScO2) related to mean arterial 
pressure (MAP) for three patients undergoing liver transplantation (A) A patient for whom 
a lower limit of cerebral autoregulation can be defined. (B) A patient who demonstrates no 
cerebral autoregulation. (C) A patient for whom no lower limit of cerebral autoregulation 
was detected (From Nissen et al., 2009 with permission) 
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and builds on the same technology of protons absorbance in the near infrared spectrum 
(NIRS) (Madsen & Secher, 1999). However in contrast to pulsoximetry, ScO2 is not coupled 
to the recording of pulse and, thereby, expresses an average rather than a maximal oxygen 
concentration of the tissue, i.e. of the brain or skeletal muscles. With spatial resolution NIRS, 
light is sampled at two distances from the emitter to prioritise absorption of light in the deep 
tissue, for the head assumed to represent the cerebral cortex (ScO2) and over a muscle (SmO2) 
oxygen saturation of haemoglobin and myoglobin. Yet, a sustained subcutaneous fat deposit 
may hinder detection of SmO2 and the thenar muscle is ideal for monitoring SmO2 since there 
is no subcutaneous fat over that muscle group (Thomson et al., 2009). 
Thus frontal lobe oxygenation by NIRS is a non-invasive recording of changes in CBF 
(Madsen & Secher, 1999) with a correlation between ScO2 and MCA Vmean (Steiner et al., 
2009). Also changes in ScO2 parallel those in internal jugular venous O2 saturation (Pott et al., 
1995;Skak et al., 1997) and NIRS is able to detect cerebral hypoperfusion (Plachky et al., 
2004). The NIRS determined ScO2 is based on the absorption of light in the spectra for 
oxygenated and deoxygenated haemoglobin and reports tissue oxygenation as a percentage 
of light absorption by oxygenated to total haemoglobin. An emitter generates light at, e.g. 
733 and 808 nm and the reflection is registered by two or more optodes placed at a distance 
of, e.g. 3 and 4 cm from the emitter to allow for the subtraction of reflections derived from 
superficial tissues of the scalp and the skull for detection of ScO2 (Grubhofer et al., 1997) (Fig. 
8). Thus with increasing distance between the emitter and the optodes, light penetrates 
deeper into the tissues and with evaluation of absorption at two distances (spatial 
resolution), absorption in deep tissue, i.e. brain, is appreciated. 
 
Fig. 8. Near infrared spectroscopy applied to the brain. Distance between the light emitter 
and the optodes 3 and 4 cm. By subtracting the superficial from the deeper reflections, 
oxygenation of brain cortex is appreciated (from Covidien, Denmark with permission) 
Of relevance for the recording of ScO2 during OLT, bilirubin absorbs light in the same 
wavelength as haemoglobin and depending of the wavelength used to derive ScO2, there 
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may be a negative influence of plasma bilirubin of the detected ScO2 (Madsen et al., 2000). 
However, even when plasma bilirubin is elevated and the reported ScO2 is low, the derived 
value reacts on changes imposed by bleeding and changes in PaCO2. 
The significant haemodynamic changes associated with OLT may lead to neurological 
complications and increased mortality in reflection of reduced cerebral vascular resistance in 
the first hour after reperfusion of the liver exposing the brain to hyperperfusion (Ardizzone 
et al., 2006). Thus in case of lacking cerebral autoregulation, CFB is affected both by a low 
and a high blood pressure and during OLT, blood pressure is likely to increase markedly 
when surgery leads to manipulation of the adrenal gland with, presumably, release of 
adrenaline into the circulation. Normally CBF is considered to be maintained within a MAP 
range from approximately 60-150 mmHg (Paulson et al., 1990). However, cerebral perfusion 
decreases already at a MAP of 80 mmHg when the decrease in blood pressure is caused by a 
low CBV and thereby a lowered CO (Madsen et al., 1995). On the other hand, cerebral 
perfusion and ScO2 may be preserved even at a MAP below 40 mmHg if CBV is not affected 
(Nissen P. et al., 2009) (Fig. 9). 
A given MAP therefore does not guarantee that cerebral perfusion is secured leading to the 
conclusion that CBF or, more likely, ScO2 should be monitored during the operation (Nissen 
et al., 2009a).  
 
Fig. 9. Cerebral oxygen saturation (ScO2) related to mean arterial pressure (MAP) including 
data obtained with a maintained central blood volume (CBV) during anaesthesia (broken 
line) and from subjects for whom the central blood volume was reduced deliberately during 
head-up tilt (full line). Normogram illustrates distribution of the lowest MAP in the 
anaesthetized patients (Modified from Nissen et al., 2009 with permission) 
Also it is to be considered that administration of phenylephrine in case of a low blood 
pressure, in an attempt to increase blood pressure to above what is might present the lower 
limit of cerebral autoregulation, is associated with a decrease rather than with the probably 
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intended increase in ScO2 (Nissen et al., 2010). Alternatively, hypotension should be 
considered in relation to a decrease in plasma calcium in response to administration of 
blood products and calcium should be supplemented to restore the physiological level (1.2 
mM). However, the use of phenylephrine may be indicated during reperfusion of the donor 
liver to reduce peripheral vasodilatation and thereby to centralise of blood accumulated in 
the splanchnic region. Alternatively, the administration of phenylephrine to increase the 
blood pressure may be replaced by the use of ephedrine that does not demonstrate the same 
negative influence on ScO2 (Nissen et al., 2010; Meng et al., 2011). 
PaCO2 has a significant influence on CBF and PaCO2 is regularly monitored by a continuous 
recording of the end-tidal CO2 tension to maintain a value of, e.g. 4,5 kPa. In that regard 
OLT is no exception, but with the reduction of the metabolic rate during the anhepatic phase 
of the OLT, a given setting of ventilation may lower PaCO2 and ventilation then needs to be 
reduced in order to maintain CBF and ScO2 (Madsen & Secher, 1999). Conversely, with 
reperfusion of the donor liver, PaCO2 increases again and often to values that exceed the 
level established in the dissection phase of the operation. Accordingly, ventilation should be 
increased at, or likely before reperfusion of the liver in order to prevent cerebral 
hyperperfusion and ventilation is thereafter gradually reduced towards the end of the 
operation guided by ScO2 as the CO2 load is eliminated by the exhaled air. 
With optodes placed over a muscle NIRS monitors muscle oxygen saturation (SmO2) and 
decreases before central hypovolaemia affects blood pressure. However, haemorrhagic 
hypotension is likely to be caused by a Bezold-Jarisch-like reflex including loss of 
sympathetic activity and, therefore, an increase in muscle blood flow and in turn SmO2 
(Madsen et al., 1995). SmO2 effectively detects central hypovolaemia (Soller et al., 2008) (Fig. 
2) and supplements, or may be used as an alternative non-invasive monitoring modality to 
SvO2 for detection of a blood loss. Ideally SmO2 provides for an early warning of ongoing 
haemorrhage and allows for direction of fluid administration before the blood loss affects 
CBF and in turn ScO2. 
9. Support to the central blood volume 
An OLT may be associated with a severe blood loss in about 20% of the patients (Massicotte et 
al., 2004). Bleeding during OLT is most common during the dissection phase for the cirrhotic 
liver associated with distended abdominal veins. Accordingly, rapid infusion systems have 
been developed which that can deliver 1.5 l of heated fluid per minute through 7 F venous 
catheter is recommended for infusion of fluids and blood products. The rapid infusion 
machine reports the accumulated amount of fluid (blood) administered and is also suited for 
infusion of small volumes to children as the fluid can be administrated with an accuracy of 
millilitres. To adults it is common to administer bolus infusions of 100 ml (occasionally 500 ml) 
over 1 min since, as mentioned, a lowering of SvO2 by 1 % corresponds typically to a volume 
deficit of ~100 ml (Ejlersen et al., 1995a). Furthermore, one or two i.v. lines can be placed for 
supplementary administration of fluid and medication. 
Since patients with end-stage liver decease present with serious haemostatic defects, 
management of coagulation during OLT is a challenge. Coagulopathy can be aggravated by 
hypothermia and acidemia, associated with increased risk of uncontrolled bleeding and 
mortality (Lier et al., 2008). Accordingly fluid, including blood products, is preheated and 
the patients are provided with a warm airflow blanket (e.g. “Bair Hugger”) covering the 
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upper part of thorax, the neck, and arms and that arrangement is usually able to maintain 
the patient’s temperature above 36º. Furthermore, frequent adjustment of CBV according to 
the individualized goal directed fluid administration strategy prevents marked changes in 
pH and arterial lactate and frequent monitoring of the plasma calcium level, with 
appropriate substitutions, supports coagulation competence. 
Yet, in order to preserve coagulation competence, there remains some disagreement. While 
one review finds that correction of coagulation defects with fresh frozen plasma (FFP) and 
platelets does not reduce the blood loss and has a negative influence on outcome (Dalmau et 
al., 2009), the local experience is that timely administration of FFP and platelets improves 
outcome (Johansson et al., 2010), a strategy supported by other studies demonstrating a 
decrease in blood loss and improvement in 24 hour and 30-day survival following early use 
of plasma and platelets (Holcomb, 2010; Holcomb et al., 2008). Discrepancy between views 
likely relate to which patients are addressed with the need for FFP and platelets indicated 
only for patients presenting with a deficit in consequence of their liver disease or provoked 
by major haemorrhage.  
It is important to monitor the OLT patient’s coagulation competence and in that regard a 
determination of the protrombin time (PT) and activated partial protrombin time (APPT) 
seems inadequate since these variables do not correlate well with clinically coagulopathy or 
bleeding condition (Murray et al., 1999; Segal & Dzik, 2005). For on-line evaluation of 
haemostasis, thrombelastographhy (TEG) is used as pioneered during OLT by Kang et al 
(Kang et al., 1985). TEG records the viscoelastic changes during coagulation by analysing 
whole blood placed in a rotating cup (Fig. 10) while a pin suspended in the blood from a 
torsion wire records the resistance to motion.  
 
Fig. 10. Thrombelastograph technology and measured variables: The clotting time (R), the 
angle (α) representing the progressive increase in clot strength, the maximal clot strength 
(MA) and the fibrinolysis (LY) (From Johannson et al,. 2010 with permission) 
Four TEG parameters are regularly reported: the clotting time (R), the angle (α) representing 
the progressive increase in clot strength, the maximal clot strength (MA), and fibrinolysis 
(LY) (Fig. 10) (Johansson, 2009). The TEG reported values correlate well with the clinical 
bleeding conditions and are recommended to direct blood product treatment together with 
a platelet count and check of the haemoglobin concentration (Plotkin et al., 2008). The TEG 
analysis can be performed in the laboratory and is locally displayed in real-time in the 
operating theatre to enable for early intervention, e.g. by administration of platelets and 
plasma in case of significantly attenuated coagulation competence. In this endeavour, it is 
considered that transfusion of platelets to 100 X 109 L-1 (rather than to the commonly used 
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guideline of 50 X 109 L-1) secures coagulation competence and additional administration of 
platelets is routinely performed before the reperfusion of the donor liver associated with 
significant use of platelets (Johansson et al., 2010). Thus, the coagulation competence of the 
patient’s blood is accentuated by the administration of FFP and saline-adenine-glucose-
mannitol (SAGM) erythrocyte suspension to a haemoglobin concentration of 6 mM 
(haematocrit 30%), making sure that plasma calcium does not decrease and calcuimcloride is 
administered frequently to maintain a reference value of 1.2 mM. 
Yet it has to be accepted that some patients have intraoperative increased consumption of 
fibrinogen and if a diffuse bleeding in combination with a reduced α and MA manifest, we 
suggest monitoring functional fibrinogen to decide whether the reduction in MA relates to 
platelet or to fibrinogen function. Attention has also been directed to the endothelial barrier 
function in response to haemorrhagic shock and the role of glycocalyx appears important to 
endothelial permeability, intracellular dysfunction, and oedema (Holcomb, 2011). 
Until recently, infusion of aprotinin was an option for OLT and aprotinin reduces 
haemorrhage by hindering fibrinolyses and thereby stabilizes the formed blood clots. 
Aprotinin has, however, been withdrawn from the marked (Dietrich, 2009) and tranexamic 
acid is the (cheaper) alternative to be administrated before surgery and again before 
reperfusion of the donor liver (Takagi et al., 2009). 
Further refinement of treatment includes control of plasma concentration of magnesium 
(Skak et al., 1996) and corrected if low (reference value 0.8 mM) and maintenance of the 
blood glucose or, conversely, administration of insulin in case the blood glucose level 
increases beyond 10 mM. Surprisingly, the blood glucose level does not decrease during the 
anhepatic phase of OLT, presumably because the kidneys supplement glucose production 
(Lauritsen et al., 2002). Also it should be considered that during massive administration of 
blood products, HR might be affected by the potassium concentration of Sag-M blood of 
approximately 50 mM. It is advised that massive administration of blood is paralleled by 
infusion of adrenaline (4-6 mg kg-1 min-1) to eliminate potassium from blood.  
10. Conclusion 
During OLT it is possible to maintain coagulation competence by timely administration of 
fresh frozen plasma and platelets together with SAGM-blood while body temperature and 
plasma pH and calcium are controlled. Notably platelets are supplemented to a reference 
value of 100 X 109 L-1 rather than 50 X 109 L-1 seems to increase survival. Even massive 
bleeding can be coped with if CBV and thereby ScO2, at all times is kept within narrow 
limits. To maintain a stable central blood volume requires that treatment of patients with 
liver disease is focused on eventually high maximal values for CO and SvO2. 
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